Current Alzheimer Research
Overview
Current Alzheimer Research is a peer-reviewed scientific journal dedicated to advancing our understanding of Alzheimer's disease. It publishes cutting-edge research articles, reviews, and commentaries that explore various aspects of the disease, including its etiology, pathogenesis, diagnosis, and treatment. The journal serves as a valuable resource for researchers, clinicians, and healthcare professionals seeking to stay updated on the latest developments in Alzheimer's research.
Details
Details
Abbr.
Curr Alzheimer Res
Publisher
Bentham Science Publishers
Start
2004
End
Continuing
Frequency
Fourteen no. a year, 2018-
p-ISSN
1567-2050
e-ISSN
1875-5828
Country
United Arab Emirates
Language
English
Specialty
Neurology
Metrics
Metrics
h-index / Ranks: 2960
103
SJR / Ranks: 7718
584
CiteScore / Ranks: 4922
5.10
JIF / Ranks: 5004
2.1
Recent Articles
1.
Buele J, Aviles-Castillo F, Palacios-Navarro G
Curr Alzheimer Res
. 2025 Mar;
PMID: 40033596
Background: In recent years, Virtual Reality (VR) has emerged as a promising tool to improve the well-being and functional capabilities of older adults. Although VR applications have shown positive results,...
2.
Gulin W, Oziemblewska M, Zajac-Lamparska L
Curr Alzheimer Res
. 2025 Feb;
PMID: 40012393
Background: Alzheimer's disease is a chronic, neurodegenerative condition that leads to a significant cognitive decline. One of the symptoms that greatly reduces the quality of daily functioning is the deterioration...
3.
Hussain M, Khan Y, Fatima R, Maqbool M, Ramalingam P, Khan M, et al.
Curr Alzheimer Res
. 2025 Feb;
PMID: 39976100
Alzheimer's disease (AD) is an age-related, progressive neurodegenerative disorder of cognition with clinical features and anatomical hallmarks of amyloid-β plaques and/or neurofibrillary tangles. New studies revealed that microglia, the native...
4.
Si Y, Meng B, Qi F
Curr Alzheimer Res
. 2025 Feb;
PMID: 39936411
Introduction: The potential therapeutic role of nicotine in Alzheimer's disease (AD) remains controversial, particularly regarding its age-dependent effects and underlying mechanisms. Method: This study investigated the impact of chronic nicotine...
5.
Radin D, Zhong S, Cerne R, Shoaib M, Smith J, Witkin J, et al.
Curr Alzheimer Res
. 2025 Feb;
PMID: 39931857
Introduction: For over a decade, AMPA receptor allosteric potentiators (AMPAkines) have shown significant effectiveness in multiple preclinical studies related to neurodegenerative and psychiatric disorders underpinned by deficient excitatory synaptic activity....
6.
Mumtaz , Ahmed F, Rabbani S, El-Tanani M, Najmi A, Ali J, et al.
Curr Alzheimer Res
. 2025 Feb;
PMID: 39931856
Alzheimer's disease (AD) is one of the leading causes of cognitive decline, which leads to dementia and poses significant challenges for its therapy. The reason is primarily the ineffective available...
7.
El Haj M, Gallouj K, Antoine P, Chapelet G
Curr Alzheimer Res
. 2025 Feb;
PMID: 39931855
Introduction: The rapid growth of mobile phone use and internet access among older adults can provide valuable opportunities for clinicians and researchers to incorporate these technologies into the memory rehabilitation...
8.
Ullah K, Almutairi M, Abbas M, Wahab A, Nayab S, Fozia F, et al.
Curr Alzheimer Res
. 2025 Feb;
PMID: 39931854
Introduction: Alzheimer's disease (AD) is a progressive neurological disorder for which no effective cure currently exists. Research has identified β-Secretase (BACE1) as a promising therapeutic target for the management of...
9.
Zhang D, Yang X, Niu H, Sun X, Cao D, Li A, et al.
Curr Alzheimer Res
. 2025 Feb;
PMID: 39902543
Introduction: This study analyzed the current status, hotspots, and development trends of tau protein research in Alzheimer's disease (AD) and to provide a reference for future research in this field....
10.
Mir M, Khosravani P, Ramezannezhad E, Saadabad F, Falahati M, Ghanbarian M, et al.
Curr Alzheimer Res
. 2025 Jan;
PMID: 39878109
Background: Alzheimer's disease (AD) is a progressive neurodegenerative condition with rising prevalence due to the aging global population. Existing methods for diagnosing AD are struggling to detect the condition in...